about
Novel therapeutic targets for pancreatic cancerEmerging concepts in pancreatic cancer medicine: targeting the tumor stromaTargeting inflammation in pancreatic cancer: Clinical translationMolecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic CancerGenetics and biology of pancreatic ductal adenocarcinomaKey players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cellsPancreatic Cancer Epidemiology, Detection, and Management.Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor GrowthMolecular targets for the treatment of pancreatic cancer: Clinical and experimental studiesc-Met as a Target for Personalized TherapyPancreatic Cancer Metabolism: Breaking It Down to Build It Back UpHepatocyte Growth Factor from a Clinical Perspective: A Pancreatic Cancer ChallengeFunctional significance of macrophages in pancreatic cancer biologyPancreatic cancer: optimizing treatment options, new, and emerging targeted therapiesTissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challengesImaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted NanovesiclesMucin-based targeted pancreatic cancer therapyDesmoplasia and chemoresistance in pancreatic cancerChronic Pancreatitis and Pancreatic CancerThe pancreas cancer microenvironmentExploiting inflammation for therapeutic gain in pancreatic cancerMet receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancerCancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated FibroblastsTargeting protein kinase C subtypes in pancreatic cancerExploring the tumor microenvironment with nanoparticlesUtilizing past and present mouse systems to engineer more relevant pancreatic cancer modelsTargeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implicationsA novel synthetic smoothened antagonist transiently inhibits pancreatic adenocarcinoma xenografts in a mouse modelPredictive modeling of in vivo response to gemcitabine in pancreatic cancerGenome-wide association study of survival in patients with pancreatic adenocarcinomaNovel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinomaSelective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression.Genetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity.Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer.A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma.Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression.Emerging HIFU applications in cancer therapy.TCGA data and patient-derived orthotopic xenografts highlight pancreatic cancer-associated angiogenesisMicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasisAscites-derived pancreatic ductal adenocarcinoma primary cell cultures as a platform for personalised medicine.
P2860
Q24564267-4273F2F6-32E3-4705-BCB2-99291734EA9AQ24627664-8C5F4809-F53F-4430-9299-01DDBE8DEE0EQ26751686-3B838653-9832-45B1-B8F0-23A320B61DCAQ26765241-7167DD0E-AE41-47DE-B1E8-056286DF3896Q26765438-2AD1B5C9-2D56-4CD5-AE4A-9CA48242FEE6Q26766065-1078DF46-1386-4D98-A23E-CA750C4E86F4Q26768506-E37025EF-DA65-4E36-8A7A-2BEEEFD2545FQ26774159-743B146E-699A-4DAC-9AF0-13FF927B3582Q26774636-91D0A834-F20A-4768-82A6-9A8EC442FC8CQ26775483-E4B25FAB-CDCA-403C-802E-84C8FED4F20CQ26780372-2B60AD73-E171-46DA-A24F-53A2AE40B008Q26781273-1C423318-E1F9-4E32-914E-01AEB8312FBFQ26786515-0C799530-EECA-409D-8A9A-EFBDC45D5EE8Q26799714-8E823BC8-FF27-4AFA-807D-BAA7ECF740D5Q26824034-9E7875CF-4039-4344-8DA0-F4AB6A70385EQ26828959-82A37EAA-64D7-422A-AEA9-7EF83720645FQ26861761-8325CF13-A10B-4F5E-9AA0-AAF0CB8BA2ECQ26864497-4E97AD5D-37B0-4172-BFF5-02DA6EF56CA7Q27025915-B805F1C6-C299-4D16-8CE2-5E4D1BA7E56FQ27026705-E8D55BF1-557B-43C2-99CB-A9FC134CBAD1Q27027661-A5EDF358-4EDC-4538-805A-EC2653089455Q27334957-BE511757-DDE1-48A8-A7DA-2F20E4159408Q28078990-3D046660-675F-431B-9B1A-BC504460A1D2Q28081364-1AC14D3C-528D-4238-AA28-FB205FB0BEF0Q28082374-F5AEA67F-0708-428C-8913-3A5974342DEDQ28083091-B054DD91-8162-4CD7-A116-A534128F817DQ28269990-1653B414-471D-4BB6-A6F1-3EA0A0F51688Q28478580-DB78E5A3-4BD8-429A-8B04-DBBCA46AF032Q28533633-3CD9CA0E-A522-48A6-A6BF-43F5D41EC8F8Q28943489-8995E162-315E-4653-8E6D-443E44773553Q30360377-9B84446E-53D9-49A9-9924-956572757276Q30384798-FFB4FFF2-63BD-40E4-B72A-5B002BB7F9EBQ30528894-9FB4C717-59A4-460D-A5C3-EE75AFC56DE9Q30541201-6F107769-DEFC-4E2F-A6DF-AFFCBE61988EQ30557486-2F00B1BF-2B4E-432D-AEB3-FCFA8CA30ADEQ30754497-764E4C9E-C711-4635-B90E-468BCC74EA5EQ30867165-2A9BDAAB-B20D-4CF7-81D9-CDCD26A79C12Q30908891-0A474975-E614-4259-9C13-D1B29623EA61Q31132024-E6C24465-2358-4820-BF8F-64BDF3C8ADF0Q33555207-22A877A8-90AF-4AD6-9493-8611006EE873
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stromal biology and therapy in pancreatic cancer.
@en
Stromal biology and therapy in pancreatic cancer.
@nl
type
label
Stromal biology and therapy in pancreatic cancer.
@en
Stromal biology and therapy in pancreatic cancer.
@nl
prefLabel
Stromal biology and therapy in pancreatic cancer.
@en
Stromal biology and therapy in pancreatic cancer.
@nl
P2093
P50
P356
P1433
P1476
Stromal biology and therapy in pancreatic cancer
@en
P2093
Albrecht Neesse
Kristopher K Frese
Malte Buchholz
Martijn P Lolkema
Mike A Jacobetz
Patrick Michl
P304
P356
10.1136/GUT.2010.226092
P407
P577
2010-10-21T00:00:00Z